Equities

GRI Bio Inc

GRI:NAQ

GRI Bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4408
  • Today's Change-0.019 / -4.17%
  • Shares traded89.75k
  • 1 Year change-99.69%
  • Beta-1.7063
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, GRI Bio Inc increased its cash reserves by 19,988.89%, or 1.80m. Cash Flow from Financing totalled 10.80m or -- of revenues. In addition the company used 8.99m for operations while cash used for investing totalled 8.00k.
Cash flow per share-38.15
Price/Cash flow per share--
Book value per share5.88
Tangible book value per share5.88
More ▼

Balance sheet in USDView more

GRI Bio Inc uses little or no debt in its capital structure.
Current ratio3.11
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.